{"id":"aciclovir","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Adrenal cortical hypofunction","Atrophoderma","Breastfeeding (mother)","Cardiovascular event risk","Cerebrovascular accident","Dehydration","Diabetes mellitus","Hemolytic uremic syndrome","Hypercholesterolemia","Hyperglycemia","Hypertensive disorder","Impaired renal function disorder","Kidney disease","Myocardial infarction","Obesity","Osteopenia","Peripheral vascular disease","Pregnancy, function","Smokes tobacco daily","Telangiectasia disorder","Thrombotic thrombocytopenic purpura","Urinary tract obstruction","Vertebral Metastases"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Aciclovir","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:22:43.233574+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:22:58.052139+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:22:50.029756+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Aciclovir","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:22:50.803327+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Human herpesvirus 1 DNA polymerase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:22:51.531333+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL184/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:22:51.433753+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"aiSummary":"Aciclovir, marketed by Assistance Publique Hopitaux De Marseille, is a well-established treatment for encephalitis due to Herpesvirus. The drug's key strength lies in its mechanism of action, which effectively targets the viral infection. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","ecosystem":[],"mechanism":{"target":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase"},"_scrapedAt":"2026-03-27T23:42:10.690Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:22:58.052285+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Encephalitis due to Herpesvirus","diseaseId":"encephalitis-due-to-herpesvirus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Genital herpes simplex","diseaseId":"genital-herpes-simplex","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Herpes labialis","diseaseId":"herpes-labialis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Herpes simplex","diseaseId":"herpes-simplex","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Herpes simplex infection of skin","diseaseId":"herpes-simplex-infection-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Herpes zoster","diseaseId":"herpes-zoster","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Recurrent Mucocutaneous Herpes Simplex","diseaseId":"recurrent-mucocutaneous-herpes-simplex","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Recurrent genital herpes simplex","diseaseId":"recurrent-genital-herpes-simplex","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Recurrent herpes simplex labialis","diseaseId":"recurrent-herpes-simplex-labialis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Suppression of Recurrent Herpes Simplex Infection","diseaseId":"suppression-of-recurrent-herpes-simplex-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Varicella","diseaseId":"varicella","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT07383649","phase":"PHASE2","title":"Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03","conditions":"Brain Cancer Metastatic, CMV Viremia","enrollment":28},{"nctId":"NCT05127395","phase":"","title":"Impact of Obesity on Clinical Outcomes in Patients Receiving Acyclovir for HSV Encephalitis\"","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-03-09","conditions":"HSV Encephalitis","enrollment":50},{"nctId":"NCT07332000","phase":"PHASE2","title":"A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec","status":"RECRUITING","sponsor":"Candel Therapeutics, Inc.","startDate":"2025-10-30","conditions":"Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)","enrollment":45},{"nctId":"NCT06391918","phase":"PHASE1","title":"Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors","status":"TERMINATED","sponsor":"GenVivo, Inc.","startDate":"2024-03-04","conditions":"Solid Tumor, Adult","enrollment":37},{"nctId":"NCT06914479","phase":"PHASE1","title":"Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2026-06-01","conditions":"Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm, Resectable Brain Neoplasm","enrollment":11},{"nctId":"NCT00492050","phase":"PHASE2","title":"Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-08-02","conditions":"Waldenstrom's Macroglobulinemia","enrollment":46},{"nctId":"NCT07448844","phase":"PHASE4","title":"Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2026-02-20","conditions":"Viral Wart, Plantar Wart, Common Warts (Verruca Vulgaris)","enrollment":40},{"nctId":"NCT03586284","phase":"PHASE2, PHASE3","title":"Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2020-03-15","conditions":"Cytomegalovirus Anterior Uveitis","enrollment":51},{"nctId":"NCT07341386","phase":"PHASE4","title":"Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-04-01","conditions":"Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex, Prevention","enrollment":62},{"nctId":"NCT07346144","phase":"PHASE1, PHASE2","title":"Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma","status":"NOT_YET_RECRUITING","sponsor":"Trogenix ltd","startDate":"2026-03","conditions":"Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma","enrollment":68},{"nctId":"NCT05536349","phase":"PHASE2","title":"Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-12-20","conditions":"Leukemia","enrollment":60},{"nctId":"NCT05468619","phase":"PHASE1","title":"Neonatal Phase 1 Valacyclovir Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-08-07","conditions":"Herpes Simplex","enrollment":17},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT07235683","phase":"PHASE4","title":"Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-12-24","conditions":"CMV, Lung Transplant Recipient","enrollment":40},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT07379203","phase":"PHASE2","title":"ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse","status":"NOT_YET_RECRUITING","sponsor":"Wits Health Consortium (Pty) Ltd","startDate":"2026-02-01","conditions":"Cytomegalovirus (CMV) Infection","enrollment":130},{"nctId":"NCT01199562","phase":"","title":"Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2010-12","conditions":"Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia","enrollment":153},{"nctId":"NCT07363031","phase":"PHASE2","title":"Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy","status":"ENROLLING_BY_INVITATION","sponsor":"Instituto Oncoclinicas","startDate":"2022-09-05","conditions":"Oral Mucositis, Head and Neck Cancer (H&N), Radiotherapy Side Effects","enrollment":84},{"nctId":"NCT07349680","phase":"PHASE3","title":"Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2023-03-15","conditions":"Postherpetic Neuralgia","enrollment":100},{"nctId":"NCT03178149","phase":"PHASE1","title":"A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration","status":"RECRUITING","sponsor":"Astellas Institute for Regenerative Medicine","startDate":"2018-07-13","conditions":"Age-Related Macular Degeneration","enrollment":42},{"nctId":"NCT06558838","phase":"PHASE2","title":"Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions","status":"COMPLETED","sponsor":"University of Utah","startDate":"2024-08-19","conditions":"Herpes Simplex Oral","enrollment":40},{"nctId":"NCT06334497","phase":"PHASE3","title":"Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-08-14","conditions":"Cytomegalovirus Infection","enrollment":80},{"nctId":"NCT05589688","phase":"PHASE1","title":"Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2024-04-09","conditions":"Obesity","enrollment":20},{"nctId":"NCT04116411","phase":"PHASE2","title":"A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cecilia Soderberg-Naucler","startDate":"2019-09-04","conditions":"Glioblastoma Multiforme","enrollment":220},{"nctId":"NCT07294547","phase":"NA","title":"Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-11-27","conditions":"Kidney Transplantation, Cytomegalovirus Infections, EBV Infection, Antiviral Prophylaxis","enrollment":80},{"nctId":"NCT04706507","phase":"PHASE3","title":"Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2021-06-29","conditions":"Acute Respiratory Failure","enrollment":205},{"nctId":"NCT07266467","phase":"PHASE4","title":"Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients","status":"RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2025-05-13","conditions":"Kidney Transplant","enrollment":290},{"nctId":"NCT03073967","phase":"PHASE3","title":"Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects","status":"COMPLETED","sponsor":"AiCuris Anti-infective Cures AG","startDate":"2017-05-08","conditions":"HSV Infection","enrollment":158},{"nctId":"NCT04710030","phase":"PHASE2","title":"Valacyclovir for Mild Cognitive Impairment","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2021-02-01","conditions":"Mild Cognitive Impairment, Herpes Simplex 1, Herpes Simplex 2","enrollment":50},{"nctId":"NCT03368664","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT","status":"TERMINATED","sponsor":"Genzyme, a Sanofi Company","startDate":"2017-10-24","conditions":"Multiple Sclerosis","enrollment":16},{"nctId":"NCT06134492","phase":"PHASE3","title":"Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2024-02-20","conditions":"Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia","enrollment":616},{"nctId":"NCT06853184","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of Artesunate","status":"RECRUITING","sponsor":"Amivas Inc.","startDate":"2025-08-01","conditions":"CMV Infection","enrollment":90},{"nctId":"NCT06034925","phase":"PHASE4","title":"Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2023-11-06","conditions":"Transplant Complication, CMV","enrollment":70},{"nctId":"NCT06798909","phase":"PHASE3","title":"Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-07-22","conditions":"Cytomegalovirus (CMV), Kidney Transplant; Complications, Kidney Diseases","enrollment":360},{"nctId":"NCT05452928","phase":"PHASE4","title":"Aciclovir Versus Placebo for HSV-2 Meningitis","status":"NOT_YET_RECRUITING","sponsor":"Jacob Bodilsen","startDate":"2026-06-01","conditions":"Herpes Simplex 2, Meningitis, Viral","enrollment":150},{"nctId":"NCT07196670","phase":"PHASE4","title":"Intralesional Vitamin D Versus Intralesional Acyclovir in Plantar Warts","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-09","conditions":"Plantar Warts Treatment","enrollment":60},{"nctId":"NCT03282916","phase":"PHASE2","title":"Anti-viral Therapy in Alzheimer's Disease","status":"COMPLETED","sponsor":"Columbia University","startDate":"2018-02-12","conditions":"Alzheimer Disease, Herpes Simplex 1, Herpes Simplex 2","enrollment":120},{"nctId":"NCT07079735","phase":"PHASE2, PHASE3","title":"Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant","status":"RECRUITING","sponsor":"Columbia University","startDate":"2025-09-12","conditions":"CMV Viremia, Heart Transplant Infection, Heart Transplant Failure and Rejection","enrollment":150},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT06102525","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma","status":"RECRUITING","sponsor":"Rznomics, Inc.","startDate":"2024-10-08","conditions":"Glioblastoma","enrollment":43},{"nctId":"NCT05098938","phase":"PHASE3","title":"A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-11-23","conditions":"Recurrent Herpes Labialis","enrollment":2020},{"nctId":"NCT07138989","phase":"PHASE2","title":"EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-19","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":10},{"nctId":"NCT04495153","phase":"PHASE2","title":"CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Candel Therapeutics, Inc.","startDate":"2020-10-13","conditions":"Non Small Cell Lung Cancer","enrollment":90},{"nctId":"NCT02768363","phase":"PHASE2","title":"Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Candel Therapeutics, Inc.","startDate":"2016-05","conditions":"Prostate Cancer","enrollment":187},{"nctId":"NCT01436968","phase":"PHASE3","title":"Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Candel Therapeutics, Inc.","startDate":"2011-09","conditions":"Prostate Cancer","enrollment":711},{"nctId":"NCT05708755","phase":"PHASE2","title":"CMV Immunity Monitoring in Lung Transplant Recipients","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2024-09-13","conditions":"Lung Transplant; Complications","enrollment":50},{"nctId":"NCT05011058","phase":"PHASE2","title":"An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas","status":"TERMINATED","sponsor":"Viracta Therapeutics, Inc.","startDate":"2021-05-28","conditions":"Epstein-Barr Virus Associated Lymphoma, EBV-Positive DLBCL, NOS, EBV-Related Non-Hodgkin Lymphoma","enrollment":102},{"nctId":"NCT03131037","phase":"PHASE1","title":"Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2017-05-04","conditions":"Lung Cancer","enrollment":12},{"nctId":"NCT06436534","phase":"NA","title":"Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-24","conditions":"Rhinitis, Allergic","enrollment":50},{"nctId":"NCT05041426","phase":"PHASE2","title":"Letermovir for CMV Prevention After Lung Transplantation","status":"COMPLETED","sponsor":"Fernanda P Silveira, MD, MS","startDate":"2021-12-06","conditions":"Lung Transplant, CMV","enrollment":16},{"nctId":"NCT04448392","phase":"PHASE1","title":"Valacyclovir in Neonatal Herpes Simplex Virus Disease","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-07-01","conditions":"Neonatal Herpes Simplex Infection","enrollment":7},{"nctId":"NCT07014397","phase":"NA","title":"Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2024-11-01","conditions":"Symptomatic Apical Periodontitis","enrollment":38},{"nctId":"NCT05198570","phase":"","title":"Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients","status":"RECRUITING","sponsor":"University of Pisa","startDate":"2021-09-15","conditions":"Herpesviridae Infections, Herpes Simplex 1, Varicella Zoster Virus Infection","enrollment":200},{"nctId":"NCT05266040","phase":"PHASE2","title":"Valacyclovir in Pain Management of Acute Apical Abscesses","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-10-25","conditions":"Acute Apical Abscess, Pain, Acute","enrollment":60},{"nctId":"NCT06474416","phase":"PHASE1","title":"A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2023-09-04","conditions":"Herpes Simplex Virus Type I Stromal Keratitis","enrollment":16},{"nctId":"NCT05550194","phase":"PHASE4","title":"VZV in the Enteric Nervous System: Pathogenesis and Consequences","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-03-27","conditions":"Achalasia","enrollment":40},{"nctId":"NCT06971913","phase":"PHASE2","title":"Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-05-20","conditions":"SLE (Systemic Lupus), CMV","enrollment":100},{"nctId":"NCT05564598","phase":"PHASE2","title":"CMV CTLs in Neonates With CMV Infection","status":"RECRUITING","sponsor":"New York Medical College","startDate":"2023-07-01","conditions":"Congenital Cytomegaloviral (CMV) Disease","enrollment":23},{"nctId":"NCT06307444","phase":"NA","title":"Ultrasound-Guided Erectro Spinae Plane Block Versus Stellate Ganglion Block for Patients With Upper Limb Acute Herpes Zoster Pain.","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-03-20","conditions":"Acute Herpes Zoster Pain Managment","enrollment":93},{"nctId":"NCT03397706","phase":"PHASE1, PHASE2","title":"Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies","status":"COMPLETED","sponsor":"Viracta Therapeutics, Inc.","startDate":"2018-03-29","conditions":"Epstein-Barr Virus-Associated Lymphoma, Lymphoproliferative Disorders","enrollment":64},{"nctId":"NCT05166577","phase":"PHASE1","title":"Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC","status":"TERMINATED","sponsor":"Viracta Therapeutics, Inc.","startDate":"2021-10-08","conditions":"Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma","enrollment":26},{"nctId":"NCT03134196","phase":"PHASE4","title":"Zoster Eye Disease Study","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2017-08-23","conditions":"Herpes Zoster Ophthalmicus","enrollment":527},{"nctId":"NCT04724447","phase":"PHASE1, PHASE2","title":"ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION","status":"RECRUITING","sponsor":"Laureate Institute for Brain Research, Inc.","startDate":"2021-11-23","conditions":"Major Depressive Disorder","enrollment":24},{"nctId":"NCT02879630","phase":"","title":"Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity","status":"RECRUITING","sponsor":"West Virginia University","startDate":"2016-08","conditions":"Obesity","enrollment":20},{"nctId":"NCT05789615","phase":"","title":"Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-04-01","conditions":"CMV Infection, Hematopoietic Stem Cell Transplantation","enrollment":200},{"nctId":"NCT03576612","phase":"PHASE1","title":"GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2018-02-27","conditions":"Glioma, Malignant","enrollment":41},{"nctId":"NCT04188327","phase":"NA","title":"Stellate Ganglion Block in Herpes Zoster","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-05-01","conditions":"Pain, Neuropathic","enrollment":208},{"nctId":"NCT06302140","phase":"PHASE1","title":"A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers","status":"TERMINATED","sponsor":"Viracta Therapeutics, Inc.","startDate":"2024-02-28","conditions":"Advanced Cancer","enrollment":8},{"nctId":"NCT06757907","phase":"NA","title":"Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-01","conditions":"Herpetic Keratitis","enrollment":20},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT05238220","phase":"","title":"Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Piedmont Healthcare","startDate":"2021-01-04","conditions":"Kidney Transplant; Complications","enrollment":37},{"nctId":"NCT01649869","phase":"PHASE2","title":"Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-02-24","conditions":"Cytomegalovirus Infection","enrollment":54},{"nctId":"NCT03004183","phase":"PHASE2","title":"SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC","status":"COMPLETED","sponsor":"The Methodist Hospital Research Institute","startDate":"2017-07-01","conditions":"Metastatic Non-small Cell Lung Cancer, Metastatic Triple-negative Breast Cancer","enrollment":57},{"nctId":"NCT00227370","phase":"PHASE3","title":"Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-07","conditions":"Cytomegalovirus Infections","enrollment":136},{"nctId":"NCT05446571","phase":"PHASE3","title":"Prenatal Treatment of Congenital Cytomegalovirus Infection with Letermovir Versus Valaciclovir","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-20","conditions":"Pregnant Women, CMV Infected Fetuses","enrollment":46},{"nctId":"NCT01149460","phase":"PHASE1","title":"Valacyclovir 1000 mg Tablet Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-09","conditions":"Healthy","enrollment":36},{"nctId":"NCT05720715","phase":"PHASE4","title":"Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2022-01-01","conditions":"Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis","enrollment":30},{"nctId":"NCT04640571","phase":"PHASE4","title":"Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2021-04-01","conditions":"Bile Salt Export Pump (BSEP) Transporter, Polysorbate 80","enrollment":18},{"nctId":"NCT05578820","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid","status":"COMPLETED","sponsor":"Gene Surgery LLC","startDate":"2022-01-01","conditions":"Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck","enrollment":21},{"nctId":"NCT06476080","phase":"NA","title":"Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes Zoster","status":"NOT_YET_RECRUITING","sponsor":"Minia University","startDate":"2024-07-05","conditions":"Acute Herpes Zoster Neuropathy","enrollment":120},{"nctId":"NCT02073097","phase":"PHASE1, PHASE2","title":"Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2015-01-28","conditions":"Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma","enrollment":48},{"nctId":"NCT06380647","phase":"NA","title":"Comparison of Prophylactic Acyclovir and Placebo in Prevention of Eczema Herpeticum in Pediatric Burns","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2019-10-01","conditions":"Herpes Virus Infection","enrollment":64},{"nctId":"NCT00650494","phase":"PHASE1","title":"Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-08","conditions":"Healthy","enrollment":66},{"nctId":"NCT00649974","phase":"PHASE1","title":"Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-05","conditions":"Healthy","enrollment":28},{"nctId":"NCT00649870","phase":"PHASE1","title":"Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-05","conditions":"Healthy","enrollment":26},{"nctId":"NCT04064697","phase":"PHASE3","title":"Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2021-04-22","conditions":"Ulcerative Colitis, Unspecified","enrollment":6},{"nctId":"NCT06344195","phase":"PHASE4","title":"Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2024-03-27","conditions":"Acute Apical Abscess","enrollment":82},{"nctId":"NCT00589875","phase":"PHASE2","title":"Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2007-03","conditions":"Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma","enrollment":52},{"nctId":"NCT06341686","phase":"PHASE3","title":"Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection","status":"NOT_YET_RECRUITING","sponsor":"Hospital do Rim e Hipertensão","startDate":"2024-05-05","conditions":"CMV Infection","enrollment":100},{"nctId":"NCT06261684","phase":"PHASE2, PHASE3","title":"Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-10-01","conditions":"Plantar Wart","enrollment":92},{"nctId":"NCT06228430","phase":"PHASE1","title":"The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions","status":"UNKNOWN","sponsor":"International Bio service","startDate":"2024-02-12","conditions":"Healthy Volunteer","enrollment":40},{"nctId":"NCT06217406","phase":"NA","title":"Preemptive Treatment With Acyclovir in Intubated and Mechanically Ventilated Patients With Herpes (PTH2)","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-03-01","conditions":"Invasive Mechanical Ventilation, HSV Throat Reactivation","enrollment":246},{"nctId":"NCT02446093","phase":"PHASE2","title":"Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Candel Therapeutics, Inc.","startDate":"2015-10","conditions":"Borderline Resectable Pancreatic Adenocarcinoma","enrollment":54},{"nctId":"NCT05492591","phase":"PHASE2","title":"A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster","status":"COMPLETED","sponsor":"Shanghai Institute Of Biological Products","startDate":"2022-10-11","conditions":"Herpes Zoster","enrollment":50},{"nctId":"NCT04037475","phase":"NA","title":"Treatment of Herpes Labialis by Photodynamic Therapy","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2020-01-01","conditions":"Photodynamic Therapy, Herpes Simplex, Labial","enrollment":24},{"nctId":"NCT04478474","phase":"","title":"Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients","status":"COMPLETED","sponsor":"New York Medical College","startDate":"2020-09-15","conditions":"Cytomegalovirus Infections","enrollment":100},{"nctId":"NCT02831933","phase":"PHASE2","title":"Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma","status":"TERMINATED","sponsor":"Eric Bernicker, MD","startDate":"2017-02-15","conditions":"Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Neoplasm of Lung, Metastatic Uveal Melanoma","enrollment":11},{"nctId":"NCT03699254","phase":"PHASE3","title":"Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2019-04-05","conditions":"Transplantation Infection, Cytomegalovirus Infections","enrollment":150},{"nctId":"NCT01997190","phase":"PHASE1","title":"Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2013-10","conditions":"Malignant Pleural Effusion, Lung Cancer, Mesothelioma","enrollment":19}],"whoEssential":true,"_emaApprovals":[],"_faersSignals":[{"count":1694,"reaction":"PYREXIA"},{"count":1144,"reaction":"PNEUMONIA"},{"count":1143,"reaction":"NAUSEA"},{"count":1116,"reaction":"FATIGUE"},{"count":1065,"reaction":"DIARRHOEA"},{"count":1027,"reaction":"OFF LABEL USE"},{"count":995,"reaction":"HEADACHE"},{"count":982,"reaction":"FEBRILE NEUTROPENIA"},{"count":935,"reaction":"ACUTE KIDNEY INJURY"},{"count":897,"reaction":"DRUG INEFFECTIVE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL184"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":915,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Aciclovir","genericName":"Aciclovir","companyName":"Assistance Publique Hopitaux De Marseille","companyId":"assistance-publique-hopitaux-de-marseille","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:22:58.052285+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}